Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 32, 2022 - Issue 11
Submit an article Journal homepage
302
Views
1
CrossRef citations to date
0
Altmetric
Review

An updated patent review of IDO1 inhibitors for cancer (2018–2022)

Peng-Fei WangChongqing Key Laboratory of Natural Product Synthesis and Drug Research, School of Pharmaceutical Sciences, Chongqing University, Chongqing, People’s Republic of ChinaView further author information
,
Li-Qiang YangChongqing Key Laboratory of Natural Product Synthesis and Drug Research, School of Pharmaceutical Sciences, Chongqing University, Chongqing, People’s Republic of ChinaView further author information
,
Zhao-Hang ShiChongqing Key Laboratory of Natural Product Synthesis and Drug Research, School of Pharmaceutical Sciences, Chongqing University, Chongqing, People’s Republic of ChinaView further author information
,
Xue-Min LiChongqing Key Laboratory of Natural Product Synthesis and Drug Research, School of Pharmaceutical Sciences, Chongqing University, Chongqing, People’s Republic of ChinaCorrespondence[email protected]
View further author information
&
Han-Yue QiuChongqing Key Laboratory of Natural Product Synthesis and Drug Research, School of Pharmaceutical Sciences, Chongqing University, Chongqing, People’s Republic of ChinaCorrespondence[email protected]
View further author information
Pages 1145-1159 | Received 04 Oct 2022, Accepted 22 Nov 2022, Published online: 06 Dec 2022

Citations (1)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (1)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.